Family Management Corp Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Family Management Corp

  • $593 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $189,120 - $223,416
-400 Reduced 66.67%
200 $112,000
Q4 2019

Feb 11, 2020
SELL
$274.13 - $376.51 $328,956 - $451,812
-1,200 Reduced 66.67%
600 $225,000
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $539,280 - $746,676
1,800 New
1,800 $563,000

Others Institutions Holding REGN

# of Institutions
1,530
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Family Management Corp Portfolio

Follow Family Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Family Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email